Evidence map›Paper›PMID 34709180›Full record

ArticleJMIR cancer2021

Predicting Hepatocellular Carcinoma With Minimal Features From Electronic Health Records: Development of a Deep Learning Model.

Chia-Wei Liang, Hsuan-Chia Yang, Md Mohaimenul Islam, Phung Anh Alex Nguyen, Yi-Ting Feng, Ze Yu Hou, Chih-Wei Huang, Tahmina Nasrin Poly, Yu-Chuan Jack Li

Abstract read
In one paragraph

Article in JMIR cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Artificial Intelligence in Dementia: A Bibliometric Study.Diagnostics (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chia-Wei LiangTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-9418-4159
Hsuan-Chia YangTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0001-9198-0697
Md Mohaimenul IslamTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0001-6026-2748
Phung Anh Alex NguyenTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-7436-9041
Yi-Ting FengTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-7271-1464
Ze Yu HouTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0001-6106-4305
Chih-Wei HuangTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-2551-6199
Tahmina Nasrin PolyTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-3484-0222
Yu-Chuan Jack LiTaipei Medical University, Taipei, Taiwan.ORCID https://orcid.org/0000-0001-6497-4232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC), usually known as hepatoma, is the third leading cause of cancer mortality globally. Early detection of HCC helps in its treatment and increases survival rates.

objectiveThe aim of this study is to develop a deep learning model, using the trend and severity of each medical event from the electronic health record to accurately predict the patients who will be diagnosed with HCC in 1 year.

methodsPatients with HCC were screened out from the National Health Insurance Research Database of Taiwan between 1999 and 2013. To be included, the patients with HCC had to register as patients with cancer in the catastrophic illness file and had to be diagnosed as a patient with HCC in an inpatient admission. The control cases (non-HCC patients) were randomly sampled from the same database. We used age, gender, diagnosis code, drug code, and time information as the input variables of a convolution neural network model to predict those patients with HCC. We also inspected the highly weighted variables in the model and compared them to their odds ratio at HCC to understand how the predictive model works.

resultsWe included 47,945 individuals, 9553 of whom were patients with HCC. The area under the receiver operating curve (AUROC) of the model for predicting HCC risk 1 year in advance was 0.94 (95% CI 0.937-0.943), with a sensitivity of 0.869 and a specificity 0.865. The AUROC for predicting HCC patients 7 days, 6 months, 1 year, 2 years, and 3 years early were 0.96, 0.94, 0.94, 0.91, and 0.91, respectively.

conclusionsThe findings of this study show that the convolutional neural network model has immense potential to predict the risk of HCC 1 year in advance with minimal features available in the electronic health records.

Indexed as

convolution neural networkdeep learningdeep learning modelhepatocellular carcinomahepatomarisk prediction

Identifiers

PMID34709180
PMCPMC8587326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.